- Home
- VERU vs ZYXI Comparison
VERU vs ZYXI Comparison
Compare VERU & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- ZYXI
- Stock Information
- Founded
- VERU 1971
- ZYXI 1996
- Country
- VERU United States
- ZYXI United States
- Employees
- VERU N/A
- ZYXI N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VERU Health Care
- ZYXI Health Care
- Exchange
- VERU Nasdaq
- ZYXI Nasdaq
- Market Cap
- VERU 54.6M
- ZYXI 44.8M
- IPO Year
- VERU 1990
- ZYXI N/A
- Fundamental
- Price
- VERU $4.29
- ZYXI $1.42
- Analyst Decision
- VERU Strong Buy
- ZYXI Hold
- Analyst Count
- VERU 3
- ZYXI 3
- Target Price
- VERU $33.33
- ZYXI $3.00
- AVG Volume (30 Days)
- VERU 158.4K
- ZYXI 82.4K
- Earning Date
- VERU 08-12-2025
- ZYXI 10-23-2025
- Dividend Yield
- VERU N/A
- ZYXI N/A
- EPS Growth
- VERU N/A
- ZYXI N/A
- EPS
- VERU N/A
- ZYXI N/A
- Revenue
- VERU $16,886,419.00
- ZYXI $144,808,000.00
- Revenue This Year
- VERU N/A
- ZYXI N/A
- Revenue Next Year
- VERU N/A
- ZYXI $7.07
- P/E Ratio
- VERU N/A
- ZYXI N/A
- Revenue Growth
- VERU 337.24
- ZYXI N/A
- 52 Week Low
- VERU $2.64
- ZYXI $1.23
- 52 Week High
- VERU $14.20
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- VERU 74.55
- ZYXI 38.40
- Support Level
- VERU $3.75
- ZYXI $1.42
- Resistance Level
- VERU $3.99
- ZYXI $1.61
- Average True Range (ATR)
- VERU 0.24
- ZYXI 0.07
- MACD
- VERU -0.01
- ZYXI 0.01
- Stochastic Oscillator
- VERU 94.34
- ZYXI 7.69
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.